APA aipamena

Chen, R., Zinzani, P. L., Lee, H. J., Armand, P., Johnson, N. A., Brice, P., . . . Moskowitz, C. H. (2019). Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087. Blood.

Chicago Style aipamena

Chen, Robert, et al. "Pembrolizumab in Relapsed or Refractory Hodgkin Lymphoma: 2-year Follow-up of KEYNOTE-087." Blood 2019.

MLA aipamena

Chen, Robert, et al. "Pembrolizumab in Relapsed or Refractory Hodgkin Lymphoma: 2-year Follow-up of KEYNOTE-087." Blood 2019.